Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organooxygen compounds
  6. Enediols
  7. NU 2058, Tocris Bioscience™

NU 2058, Tocris Bioscience™

Catalog No. 313550
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
31-355-0 50 mg
31-351-0 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 31-355-0 Supplier R&D Systems Supplier No. 3135/50
This item is not returnable. View return policy

Description

Cdk1 and cdk2 inhibitor

Cyclin-dependent kinase (cdk) 1 and cdk2 inhibitor (Ki values are 5 and 12 μM respectively). Inhibits growth of human tumor cells in vitro (mean GI50 = 13 μM). Also inhibits DNA topoisomerase II ATPase activity (IC50 = 300 μM).

Chemical Identifiers

CAS 161058-83-9
Molecular Formula C12H17N5O
Molecular Weight (g/mol) 247.302
InChI Key MWGXGTJJAOZBNW-UHFFFAOYSA-N
Synonym 6-cyclohexylmethoxy-9h-purin-2-amine, 6-o-cyclohexylmethyl guanine, 2-amino-6-cyclohexylmethoxypurine, 2-amino-6-cyclohexylmethyl oxy purine, 6-cyclohexylmethoxy-7h-purin-2-amine, 9h-purin-2-amine, 6-cyclohexylmethoxy, o-cyclohexylmethylguanine, o6-cyclohexylmethylguanine, d0r1ft, d0sj6y
PubChem CID 4564
IUPAC Name 6-(cyclohexylmethoxy)-7H-purin-2-amine
SMILES C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)N

Specifications

Quantity 50 mg
Formula Weight 247.3
Percent Purity >99%
Chemical Name or Material NU 2058

Safety and Handling

Recommended Storage Store at +4°C
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.